"targeted therapy" trang 10 - tải miễn phí từ tailieunhanh
Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection

Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection
10    29    1
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer
10    18    1
Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
11    16    1
Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer

Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
13    1    1
Sintilimab Plus Apatinib and Chemotherapy as Second-/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A prospective, Single-Arm, phase II trial

Sintilimab Plus Apatinib and Chemotherapy as Second-/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A prospective, Single-Arm, phase II trial
10    2    1
Efficacy and safety analysis of TACE+sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: A retrospective study

Efficacy and safety analysis of TACE+sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: A retrospective study
11    5    1
Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan
10    7    1
The INFINITY study protocol: A retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice

The INFINITY study protocol: A retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
7    7    1
Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data

Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
19    8    1
Implication of extrinsic and intrinsic apoptotic pathways in the targeted therapy of hepatocellular carcinoma using aptamer‑labeled viramidine nanoparticles

Implication of extrinsic and intrinsic apoptotic pathways in the targeted therapy of hepatocellular carcinoma using aptamer‑labeled viramidine nanoparticles
14    7    1
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: A retrospective study

High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: A retrospective study
9    2    1
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: The NEW BEACON study

A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: The NEW BEACON study
6    8    1
Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: Difference exists in the strength of surrogacy in various trial settings

Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: Difference exists in the strength of surrogacy in various trial settings
13    1    1
Efficacy and safety analysis of TACE+Donafenib+Toripalimab versus TACE+Sorafenib in the treatment of unresectable hepatocellular carcinoma: A retrospective study

Efficacy and safety analysis of TACE+Donafenib+Toripalimab versus TACE+Sorafenib in the treatment of unresectable hepatocellular carcinoma: A retrospective study
11    8    1
Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: A case report

Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: A case report
7    6    1
Tumor mutational burden is associated with poor outcomes in diffuse glioma

Tumor mutational burden is associated with poor outcomes in diffuse glioma
12    96    0
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice

Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
18    83    0
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
11    77    1
African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks

African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks
13    50    1
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma
7    43    1